BIP1 is a murine IgG antibody capable of enhancing the IgE binding to Bet v
1, the major birch pollen allergen, We have previously generated a mimotop
e of BIP1, designated Bet mim 1, from a constrained phage display peptide l
ibrary. We dem onstrated that oral immunization of BALB/c mice with the Bet
mim 1 mimotope resulted in the induction of Bet v I-specific IgG, The aim
of this study was to test the influence of such an oral immunization with B
et mim 1 on a subsequent type I allergic response to Bet v 1, Phages displa
ying Bet mim 1 or control mimotopes, or PBS alone, were delivered to BALB/c
mice by intragastric gavages prior to systemic sensitization with recombin
ant Bet v I and AI(OH),, an adjuvant inducing preferentially IgE antibody r
esponses. Only mice fed with Bet mim 1-phages displayed substantially enhan
ced type I allergic skin reactivity to Bet v 1, as compared to mice pretrea
ted with control mimotopes or PBS, A gastric digestion assay indicated that
Bet v I and its homologue from apple, Mal d 1, were degraded within second
s under physiological conditions. In contrast, phage-displayed mimotopes we
re resistant to digestion. Our data indicate that allergen mimics in the di
et that resist digestion, can induce allergen specific IgG able to enhance
an allergic response. We therefore conclude that sensitization via the oral
route may represent a mechanism for aggravating type I allergic reactions,
probably leading to an earlier onset of symptoms even at lower allergen do
sage.